1. Home
  2. OCUL vs TIC Comparison

OCUL vs TIC Comparison

Compare OCUL & TIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • TIC
  • Stock Information
  • Founded
  • OCUL 2006
  • TIC 1991
  • Country
  • OCUL United States
  • TIC United States
  • Employees
  • OCUL N/A
  • TIC N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • TIC
  • Sector
  • OCUL Health Care
  • TIC
  • Exchange
  • OCUL Nasdaq
  • TIC Nasdaq
  • Market Cap
  • OCUL 2.3B
  • TIC 2.3B
  • IPO Year
  • OCUL 2014
  • TIC N/A
  • Fundamental
  • Price
  • OCUL $12.17
  • TIC $10.94
  • Analyst Decision
  • OCUL Strong Buy
  • TIC Buy
  • Analyst Count
  • OCUL 7
  • TIC 2
  • Target Price
  • OCUL $17.83
  • TIC $13.50
  • AVG Volume (30 Days)
  • OCUL 2.2M
  • TIC 1.6M
  • Earning Date
  • OCUL 11-13-2025
  • TIC 11-03-2025
  • Dividend Yield
  • OCUL N/A
  • TIC N/A
  • EPS Growth
  • OCUL N/A
  • TIC N/A
  • EPS
  • OCUL N/A
  • TIC N/A
  • Revenue
  • OCUL $56,664,000.00
  • TIC $1,113,179,000.00
  • Revenue This Year
  • OCUL N/A
  • TIC $43.98
  • Revenue Next Year
  • OCUL $18.87
  • TIC $43.29
  • P/E Ratio
  • OCUL N/A
  • TIC N/A
  • Revenue Growth
  • OCUL N/A
  • TIC 4.23
  • 52 Week Low
  • OCUL $5.79
  • TIC $8.76
  • 52 Week High
  • OCUL $13.85
  • TIC $14.28
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 46.53
  • TIC N/A
  • Support Level
  • OCUL $12.27
  • TIC N/A
  • Resistance Level
  • OCUL $13.07
  • TIC N/A
  • Average True Range (ATR)
  • OCUL 0.62
  • TIC 0.00
  • MACD
  • OCUL -0.10
  • TIC 0.00
  • Stochastic Oscillator
  • OCUL 7.92
  • TIC 0.00

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About TIC Acuren Corporation Common Stock

Acuren Corp operates as a provider of critical asset integrity services. The company provides testing, inspection, engineering and lab testing services in different industrial markets such as chemical, pipeline, refinery, power generation, oilsands, automotive, aerospace, mining, manufacturing, renewable energy, and pulp and paper. The company's service line includes Nondestructive Testing (NDT) techniques such as radiography, ultrasonic testing, magnetic particle inspection, penetrant testing, etc., Rope Access Technician Solutions (RAT), and Engineering and Lab Testing. The company has two operating and reportable segments, which are the United States, generating maximum revenue, and Canada.

Share on Social Networks: